{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T06:10:01Z","timestamp":1749449401687,"version":"3.41.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"22","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,9]]},"DOI":"10.1093\/eurheartj\/ehaf201","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T17:17:48Z","timestamp":1744132668000},"page":"2063-2065","source":"Crossref","is-referenced-by-count":0,"title":["Mode of revascularization for ischaemic cardiomyopathy: comparing apples with oranges?"],"prefix":"10.1093","volume":"46","author":[{"given":"Kayla","family":"Chiew","sequence":"first","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London , Du Cane Rd, London W12 0HS ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shayna","family":"Chotai","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London , Du Cane Rd, London W12 0HS ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3752-5532","authenticated-orcid":false,"given":"Rasha","family":"Al-Lamee","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London , Du Cane Rd, London W12 0HS ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"2025060901513912000_ehaf201-B1","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0735-1097(86)80325-4","article-title":"Reversible ischemic left ventricular dysfunction: evidence for the \u2018hibernating myocardium\u2019","volume":"8","author":"Braunwald","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"2025060901513912000_ehaf201-B2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0002-8703(89)90685-6","article-title":"The hibernating myocardium","volume":"117","author":"Rahimtoola","year":"1989","journal-title":"Am Heart J"},{"key":"2025060901513912000_ehaf201-B3","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N Engl J Med"},{"key":"2025060901513912000_ehaf201-B4","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","article-title":"Coronary-artery bypass surgery in patients with ischemic cardiomyopathy","volume":"374","author":"Velazquez","year":"2016","journal-title":"N Engl J Med"},{"key":"2025060901513912000_ehaf201-B5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"2025060901513912000_ehaf201-B6","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","article-title":"Percutaneous revascularization for ischemic left ventricular dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N Engl J Med"},{"key":"2025060901513912000_ehaf201-B7","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"2025060901513912000_ehaf201-B8","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"2025060901513912000_ehaf201-B9","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1093\/eurheartj\/ehaf080","article-title":"Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysis","volume":"46","author":"Ryan","year":"2025","journal-title":"Eur Heart J"},{"key":"2025060901513912000_ehaf201-B10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0140-6736(03)13801-9","article-title":"Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial","volume":"362","author":"Cleland","year":"2003","journal-title":"Lancet"},{"key":"2025060901513912000_ehaf201-B11","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1001\/jamacardio.2023.3803","article-title":"Viability and outcomes with revascularization or medical therapy in ischemic ventricular dysfunction: a prespecified secondary analysis of the REVIVED-BCIS2 trial","volume":"8","author":"Perera","year":"2023","journal-title":"JAMA Cardiol"},{"key":"2025060901513912000_ehaf201-B12","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1161\/CIRCULATIONAHA.123.065300","article-title":"Arrhythmia and death following percutaneous revascularization in ischemic left ventricular dysfunction: prespecified analyses from the REVIVED-BCIS2 trial","volume":"148","author":"Perera","year":"2023","journal-title":"Circulation"},{"key":"2025060901513912000_ehaf201-B13","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jchf.2013.04.012","article-title":"The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results","volume":"1","author":"Carson","year":"2013","journal-title":"JACC Heart Fail"},{"key":"2025060901513912000_ehaf201-B14","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1056\/NEJMoa2401479","article-title":"Beta-blockers after myocardial infarction and preserved ejection fraction","volume":"390","author":"Yndigegn","year":"2024","journal-title":"N Engl J Med"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/46\/22\/2063\/62888512\/ehaf201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/46\/22\/2063\/62888512\/ehaf201.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T05:51:44Z","timestamp":1749448304000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/46\/22\/2063\/8108163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":14,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2025,4,8]]},"published-print":{"date-parts":[[2025,6,9]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehaf201","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"type":"print","value":"0195-668X"},{"type":"electronic","value":"1522-9645"}],"subject":[],"published-other":{"date-parts":[[2025,6,7]]},"published":{"date-parts":[[2025,4,8]]}}}